SCHEMBL9622343

SCHEMBL9622343

Cc1cccc2c1-c1c(C)cccc1C2CO

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
HTR2C P28335 8/20 0.37
HTR2A P28223 4/20 0.37
HTR2B P41595 4/20 0.37
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
TRPA1 O75762 2/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA7 P43166 2/20 0.33
CA9 Q16790 2/20 0.33
MYC P01106 1/20 0.33
CD44 P16070 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2A6 P11509 1/20 0.33
ATM Q13315 1/20 0.33
TSHR P16473 1/20 0.32
ACHE P22303 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9449421 0.87 HTR2A (0.42) HTR2CHTR2AHTR2BMEN1KMT2A
SCHEMBL28618542 0.75 HTR2B (0.46) ALDH1A1HTR2CHTR2AHTR2BTRPA1
SCHEMBL30838752 0.75 HTR2B (0.46) ALDH1A1HTR2CHTR2AHTR2BTRPA1
SCHEMBL11526876 0.73 HTR2A (0.40) HTR2CHTR2AMEN1KMT2ATSHR
Hydrochloric Acid SCHEMBL8916641 0.71 MEN1 (0.34) ALDH1A1HTR2CHTR2AHTR2BMEN1
SCHEMBL9449328 0.71 HTR2A (0.42) ALDH1A1HTR2CHTR2AHTR2BMEN1
SCHEMBL18515869 0.71 HTR2A (0.42) ALDH1A1HTR2CHTR2AHTR2BMEN1
SCHEMBL11526446 0.68 HTR2A (0.33) ALDH1A1HTR2CHTR2AHTR2BMEN1
SCHEMBL27335604 0.68 HTR2A (0.44) ALDH1A1HTR2CHTR2AHTR2BMEN1
SCHEMBL9622137 0.68 MYC (0.44) ALDH1A1HTR2CHTR2AHTR2BCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5079260-A Side effect reduction; fluorene derivatives NOVA PHARMACEUTICAL CORPORATION (US) 1992-01-07 US disclosed
WO-1991018596-A1 METHODS FOR TREATING INFLAMMATION AND COMPOUNDS AND COMPOSITIONS SUITABLE FOR USE THEREIN WEITZBERG MOSHE (US) 1991-12-12 WO disclosed